Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 09 Jan 2014  |  Global  |  Market Research

    Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry

    Increasing Volume and Decreasing Value

    This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is cover...

    $4,950.00
  2. 16 Jan 2014  |  Global  |  Market Research

    Analysis of the Global Biosimilars Market

    Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth

    Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline asse...

    $10,000.00
  3. 04 Feb 2014  |  North America  |  Market Research

    Product and Pipeline Analysis of the Global Parkinson's Disease Therapeutics Market

    This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...

    $3,950.00
  4. 27 Feb 2014  |  North America  |  Market Research

    US and European Sleep Disorder Diagnostic Devices Market

    Cost-effective Solutions in Home Sleep Tests Stir Market Growth

    This research service studies the qualitative and the quantitative aspects of the sleep disorder diagnostic devices market in Europe and the United States. The study includes clinical polysomnogram (PSG) systems and ambulatory PSG systems. The countries in this research include: Germany, France, Italy, Spain, the United Kingdom, the United States, ...

    $4,950.00
  5. 18 Apr 2014  |  North America  |  Market Research

    Global Regulatory Overview For Companion Diagnostics Market

    Nurturing Partnerships for Companion Diagnostics Requires Efficient Understanding of the Regulatory Landscape

    This study aims to cover the regulatory outlook and the diagnostics and drug approval process in the US, Europe, India, China, Japan and Brazil. Comparative analysis enables competitors to understand various regulatory hurdles and to position their products in pipeline better and plan for costs. Comparative analysis also enables an understanding of...

    $1,500.00
  6. 02 May 2014  |  North America  |  Market Research

    US In Vitro Diagnostics (IVD) Market Data

    Early Detection Provides New Opportunities for the IVD Industry

    This study provides data for the US in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, tissue diagnostics, self-monitoring blood glucose, and immunochemistry are the segments in this market. Market revenues have been included in this de...

    $3,950.00
  7. 02 May 2014  |  North America  |  Market Research

    US Urinalysis Market Data

    Pressure to Improve TAT Necessitates Automating Urinalysis Workflow Processes

    This study provides market data for the US Urinalysis Market. Market segments include sediment and dipstick. Sediment and dipstick are further segmented by instruments and reagents. In this deliverable, market revenues, installed base units, and market share are included. Further analysis will be provided in a separate deliverable to accompany this...

    $3,950.00
  8. 05 May 2014  |  North America  |  Market Research

    Global Regenerative Medicine Market

    A New Era in Human Health to Resolve Unmet Medical Needs

    This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study cov...

    $3,950.00
  9. 06 May 2014  |  North America  |  Market Research

    US Nuclear Medicine and PET Imaging Systems Market

    Molecular Imaging Falls Short of Realizing Full Growth Potential

    This research service pertains to the US market for nuclear medicine and positron emission tomography (PET) imaging systems. Providing thorough market sizing and forecast of market revenue, unit shipments, procedure volumes, average pricing, and installed base, the study analyzes market trends, drivers and restraints, along with the reimbursement a...

    $4,950.00
  10. 20 May 2014  |  Asia Pacific  |  Market Research

    Russia In Vitro Diagnostics (IVD) Market Data

    Early Detection Provides New Opportunities for IVD Industry

    This study provides data for the Russian in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, immunochemistry, and others namely, tissue diagnostics and self-monitoring blood glucose, are the segments discussed in this market. Market reve...

    $3,950.00